$2.410
+0.160 (+6.64%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de RADX por análisis de gráficos similares
Alphio's RADX stock price prediction model matches the current Radiopharm Theranostics Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.41 (-0.18%). The 1-week path is $2.44 (+1.24%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Radiopharm Theranostics Ltd?
Radiopharm Theranostics Limited (RADX) appears to be a good buy right now due to its recent positive clinical trial results and a strong analyst price target. The stock closed at $2.41, which is significantly below the analyst's target of $6, suggesting a potential upside of 148.95%. Additionally, the stock has shown a recent increase of 6.64% in price, indicating a positive short-term momentum. However, the stock has a high forward P/E of 0 and a negative price-to-earnings ratio, which presents a risk if the clinical trials do not meet expectations.
RADX cerró en $2.41 el Friday, tras subir +6.64%
Radiopharm Theranostics Ltd (RADX) last closed at $2.41, gaining +6.64%. These facts feed the 1-day and 1-week RADX price prediction above.
Factores de la previsión
Los factores de la previsión de Radiopharm Theranostics Ltd (RADX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de RADX, ordenadas por similitud.
Análisis de estacionalidad de RADX
Historically the probability of a positive August return for RADX is 51.22%. September offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de RADX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $4.14 | $4.65 | $5.47 | +93.09% |
| Sep 2026 | $4.23 | $4.49 | $4.61 | +86.30% |
| Oct 2026 | $4.17 | $4.76 | $5.42 | +97.65% |
| Nov 2026 | $4.55 | $5.35 | $5.42 | +122.16% |
| Dec 2026 | $4.18 | $4.42 | $4.44 | +83.58% |
En 2026, se proyecta que Radiopharm Theranostics Ltd (RADX) oscile entre $4.14 y $5.47.
Previsión mensual de Radiopharm Theranostics Ltd para 2026
En Aug de 2026, se proyecta que Radiopharm Theranostics Ltd promedie $4.65, con un mínimo de $4.14 y un máximo de $5.47.
En Sep de 2026, se proyecta que Radiopharm Theranostics Ltd promedie $4.49, con un mínimo de $4.23 y un máximo de $4.61.
En Oct de 2026, se proyecta que Radiopharm Theranostics Ltd promedie $4.76, con un mínimo de $4.17 y un máximo de $5.42.
En Nov de 2026, se proyecta que Radiopharm Theranostics Ltd promedie $5.35, con un mínimo de $4.55 y un máximo de $5.42.
En Dec de 2026, se proyecta que Radiopharm Theranostics Ltd promedie $4.42, con un mínimo de $4.18 y un máximo de $4.44.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.